Page last updated: 2024-10-27

foscarnet and Leukemia L 1210

foscarnet has been researched along with Leukemia L 1210 in 2 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Phadtare, S1
Kessel, D1
Corbett, TH1
Renis, HE1
Court, BA1
Zimlicka, J1
Vaghefi, MM1
McKernan, PA1
Robins, RK1

Other Studies

2 other studies available for foscarnet and Leukemia L 1210

ArticleYear
Unsaturated and carbocyclic nucleoside analogues: synthesis, antitumor, and antiviral activity.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:1

    Topics: Adenosine Deaminase; Animals; Antimetabolites, Antineoplastic; Antiviral Agents; Cell Line; Cell Sur

1991
Synthesis and antiviral activity of certain nucleoside 5'-phosphonoformate derivatives.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:8

    Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Deltaretrovirus; Foscarnet; Hydrogen-Ion

1986